Who are LD: Lidocaine and dexamethasone's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ld-lidocaine-and-dexamethasone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

LD: Lidocaine and dexamethasone — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LD: Lidocaine and dexamethasone (LD: Lidocaine and dexamethasone) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic with corticosteroid combination. Area: Pain management, Anesthesia, Inflammation.

marketed Local anesthetic with corticosteroid combination Voltage-gated sodium channels (lidocaine); glucocorticoid receptor (dexamethasone) Pain management, Anesthesia, Inflammation Small molecule Live · refreshed every 30 min

Target snapshot

LD: Lidocaine and dexamethasone (LD: Lidocaine and dexamethasone) — B.P. Koirala Institute of Health Sciences. Lidocaine provides local anesthesia by blocking sodium channels in nerve fibers, while dexamethasone reduces inflammation and swelling at the injection or application site.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
LD: Lidocaine and dexamethasone TARGET	LD: Lidocaine and dexamethasone	B.P. Koirala Institute of Health Sciences	marketed	Local anesthetic with corticosteroid combination	Voltage-gated sodium channels (lidocaine); glucocorticoid receptor (dexamethasone)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic with corticosteroid combination class)

B.P. Koirala Institute of Health Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LD: Lidocaine and dexamethasone — Competitive Intelligence Brief. https://druglandscape.com/ci/ld-lidocaine-and-dexamethasone. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab